US Pharma MarketingAI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
Artificial intelligence use cases across the federal health department spiked between fiscal years 2024 and 2025— led by a 148% year-over-year increase at the Food and Drug Administration (FDA), a There was a big uptick in the use of AI across all HHS agencies in 2025, though analysts note some use cases may “reflect new reporting requirements instead of new deployments." Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthalmology Cell & Gene Therapy Drug Development Small Molecule Research & Development Fierce…
There was a big uptick in the use of AI across all HHS agencies in 2025, though analysts note some use cases may “reflect new reporting requirements instead of new deployments."
Source: FierceBiotech